SES Backs Seraphim Space Fund Launch
SES announced today that it is investing in the Seraphim Space Fund in order to support innovation in the satellite industry and to encourage Research and Development (R&D) efforts across the markets served by satellite. The world-leading satellite operator will also participate in the fund’s Advisory Board.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170913006694/en/
Seraphim Space Fund is a new venture capital fund launched by Seraphim Capital. Its primary focus is to invest in projects that are commercialising data about the Earth, collected by either satellite or Remotely Piloted Aircraft Systems (RPAS). Seraphim also invests in the broader technology ecosystem which supports the satellite and RPAS infrastructures and applications across a broad range of vertical markets, including construction, logistics, agriculture, finance, with a key focus on the insurance market - using insights from airborne data to evaluate risk, monitor assets and assess claims.
“SES is focused on providing reliable and secure satellite solutions to customers in our Video and Networks market segments. By investing in the Seraphim Space Fund, we will be working with other leading industry partners to push beyond the capabilities of satellites. We look forward to identifying innovative developments along the value chains and key markets,” said Christophe De Hauwer, Chief Strategy & Development Officer at SES.
SES is renowned for its leading role in technological and business innovation in the satellite industry, and actively promotes innovation through various initiatives.
Follow us on:
SES is the world-leading satellite operator and the first to deliver a differentiated and scalable GEO-MEO offering worldwide, with more than 50 satellites in Geostationary Earth Orbit (GEO) and 12 in Medium Earth Orbit (MEO). SES focuses on value-added, end-to-end solutions in two key business units: SES Video and SES Networks. The company provides satellite communications services to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions. SES’s portfolio includes ASTRA, O3b and MX1, a leading media service provider that offers a full suite of innovative digital video and media services. SES is listed on the Euronext Paris and Luxembourg Stock Exchange (ticker: SESG). Further information available at: www.ses.com
About Seraphim Capital
Seraphim is a London-based venture capital fund manager. Seraphim typically invests at Series A stage into IP-led businesses that have the potential to redefine large existing markets or create entirely new ones. Over the last decade this has included artificial intelligence (computer vision, neural networks, machine learning), the Internet of Things (software, sensors) and advanced materials (polymers, semiconductors). Collectively, the Seraphim team has more than 100 years’ experience, having invested in over 180 early and growth stage businesses.
Corporate Communications & PR
Tel. +352 710 725 500
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
FL-MLB22.9.2018 00:15 | pressemeddelelse
American Airlines Announces Nonstop Philadelphia (PHL) to Orlando Melbourne (MLB)
NY-BCW/PALLADINO21.9.2018 19:45 | pressemeddelelse
Amy Palladino Joins BCW as Executive Vice President, Managing Director, Corporate Practice
HEIDELBERG-ENGINEERING21.9.2018 18:43 | pressemeddelelse
Heidelberg Engineering Announces the CE-Marking of ANTERION
JEDOX21.9.2018 17:48 | pressemeddelelse
Florian Winterstein Becomes New CEO of Jedox
AVINOR21.9.2018 16:39 | pressemeddelelse
Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter
MA-TAKEDA-PHARMACEUTICAL21.9.2018 15:32 | pressemeddelelse
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum